share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Stewart Jeffrey Ryan

SEC announcement ·  Mar 21 05:03
Summary by Futu AI
Jeffrey Ryan Stewart, EVP and Chief Commercial Officer of AbbVie Inc., completed a series of transactions on March 18, 2024, involving the company's common stock. Stewart exercised options to acquire 26,110 shares at a price of $61.36 per share. Subsequently, he sold a total of 58,949 shares through open market transactions at prices ranging from $178.69 to $179.03, resulting in a total market value of $10,539,508.07. After these transactions, Stewart's direct holdings in AbbVie common stock amounted to 60,941 shares. Additionally, it was reported that 1,338 shares are held indirectly by Stewart's spouse in trust.
Jeffrey Ryan Stewart, EVP and Chief Commercial Officer of AbbVie Inc., completed a series of transactions on March 18, 2024, involving the company's common stock. Stewart exercised options to acquire 26,110 shares at a price of $61.36 per share. Subsequently, he sold a total of 58,949 shares through open market transactions at prices ranging from $178.69 to $179.03, resulting in a total market value of $10,539,508.07. After these transactions, Stewart's direct holdings in AbbVie common stock amounted to 60,941 shares. Additionally, it was reported that 1,338 shares are held indirectly by Stewart's spouse in trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.